SCHEMBL10175495

SCHEMBL10175495

O=C(O)c1ccccc1Nc1ccc(C2CCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.58
PTGS1 P23219 1/20 0.54
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
SIRT2 Q8IXJ6 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
TEAD4 Q15561 1/20 0.50
ACMSD Q8TDX5 2/20 0.49
DHODH Q02127 6/20 0.48
ABCC1 P33527 2/20 0.48
MAPK8 P45983 1/20 0.47
TTR P02766 1/20 0.47
SERPINE1 P05121 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPY5R Q15761 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1962948 0.88 ACMSD (0.46) FABP4PTGS1AKR1C3AKR1C2SIRT2
SCHEMBL22453284 0.84 SIRT2 (0.60) SIRT2MEN1KMT2AALDH1A1SERPINE1
SCHEMBL22452463 0.82 DHODH (0.46) FABP4PTGS1AKR1C3AKR1C2MEN1
SCHEMBL15178352 0.82 KMT2A (0.41) FABP4SIRT2MEN1KMT2AALDH1A1
SCHEMBL18109767 0.81 FABP4 (0.85) FABP4PTGS1AKR1C3AKR1C2SIRT2
SCHEMBL7841736 0.78 FABP4 (0.85) FABP4PTGS1AKR1C3AKR1C2SIRT2
SCHEMBL1335958 0.78 NPY5R (0.60) PTGS1MEN1KMT2AALDH1A1MAPT
SCHEMBL11199863 0.78 NPY5R (0.60) PTGS1MEN1KMT2AALDH1A1MAPT
Fenamic Acid SCHEMBL25828 0.78 FABP4 (0.92) FABP4PTGS1AKR1C3AKR1C2MEN1
Fenamic Acid SCHEMBL29622832 0.78 FABP4 (0.92) FABP4PTGS1AKR1C3AKR1C2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022116-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX CORNING INCORPORATED 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022116-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL CONDITION(S) RELATED TO GPR35 AND/OR GPR35-HERG COMPLEX GPR35, GPR65, GPR68 FABP4 501/4885PTGS1 802/4885AKR1C3 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.